aeruginosa isolates. Focusing on the lower detection threshold, the difference was significant between the two qPCR assays with a detection threshold of 10 CFU/mL for the oprL qPCR versus 730 CFU/mL for the multiplex PCR. The sensitivity of the in vitro

oprL qPCR in our study was higher than that recommended by the French guidelines, i.e. a detection threshold of 102 CFU/mL for CF sputum sample [37]. The third criterion needed for early P. aeruginosa detection technique, in particular, for molecular one, is to have a high specificity to prevent false positive amplification. When looking at a large panel of genes described in the literature e.g. oprI, oprL, rrl, ecfX, gyrB, or rrs, specificity varied from 74% to 100% [14, 17, 34–36, 38]. In our study, specificity of the oprL qPCR was evaluated at 73% versus 90% www.selleckchem.com/products/MK 8931.html for the Captisol multiplex PCR. Four previous studies have tested the specificity of the oprL primer pairs and found different values ranging from 87% to 100% [22, 34, 35, 38]. Again, previous studies looking at gyrB and ecfX genes found a better specificity (100%) than in our study [14, 35]. Different reasons could TPCA-1 mouse explain these discrepancies.

Firstly, our specificity could have been influenced by a larger panel of closely related non P. aeruginosa gram-negative bacilli (41 isolates including 16 different species). Secondly, all the bacterial isolates (except one reference strain) were recovered from clinical samples (CF or non CF) or from environmental Interleukin-3 receptor samples. These isolates, which were recovered from CF could have undergone genetic exchange with other species in the natural CF

microenvironment, especially P. aeruginosa, influencing the specificity of the molecular method [38]. Thus, specificity in previous studies could have been overestimated [14, 34, 35, 38]. As highlighted by Anuj et al. [14, 35], the higher specificity of our results for the multiplex PCR may be explained by the fact that we amplified at least 2 DNA targets. The use of two probes simultaneously seems to improve the specificity, providing at the same time the detection and the confirmation of the presence of P. aeruginosa[14, 19]. Interestingly, our bacterial species that cross-reacted with the oprL qPCR did not do so when oprL qPCR was combined with the multiplex PCR thus allowing 100% specificity. These results were successfully validated by the sputum samples of CF patients from the never or free categories according to the definition of Leeds [32]. The ex vivo experiments put forward a significant difference between the culture-based quantification and the qPCR-based quantification. In average, the qPCR detected 100 times more CFU of P. aeruginosa than the culture did. This could be explained by different hypotheses. First, the difference in utilized sputum volumes contributes to this discrepancy. Indeed, only 10 μl were cultured whereas 1 ml was extracted for the qPCR.